Questions? +1 (202) 335-3939

Trusted News Since 1995

A service for political professionals · Monday, November 4, 2024 · 757,685,251 Articles · 3+ Million Readers

News Search | All News Topics > EU Politics News Topics: By Country

Search Tips

Here you can find useful examples and description about searching the news archive. Read it carefully to get the best results. If you need more help, please contact us.

Quick Overview

Searching is case insensitive. Words music and mUSIC return the same results.
Some of the common words like the, is, etc. are not included in your search.

Search Term Syntax

The symbol "|" stands for OR and symbol "&" stands for AND.

Term	Description
\|	Using \| operator gives you articles for every keyword in the search term.
&	Using & operator gives you only those articles that contain all keywords in the string.
" " (quotation marks)	Using quotation marks limits your search for exact phrases.
* (asterisk sign)	Using an asterisk sign gives you variations of aroot keyword. You cannot use it in phrases.
(parenthesis)	You can use parenthesis to adjust the priority of your search phrase evaluation (as common math/boolean expressions).

Examples

Keywords (search phrase)	Description
music	will search for any articles that contain the word music
music \| band \| song	will search for articles containing any of the keywords
nhl & hockey	will search for articles containing both words. (Note: & can be omitted in this case)
"white house" \| senate	will search for articles containing the phrase white house or the word senate
"flower show" & tulip	will search for articles containing both the phrase flower show and the word tulip
bank*	will search for articles containing bank, banks, banking, banker etc. Using * (asterisk sign) gives you variations of the root keyword.
student* & ( protest* \| demonstrat* )	will search for articles containing the words student or students, etc. in combinations with protest, protests, demonstrate, demonstration, etc.

Need more help? Contact us at our helpdesk.

Published on 15:58 GMT

Novo Nordisk Signs $285M GLP-1 Deal With Danish Neighbor Ascendis

Novo Nordisk is sticking close to home for its latest GLP-1 deal, signing a $285 million partnership with fellow Danish company Ascendis Pharma to work on new therapeutics for metabolic and cardiovascular diseases. Ascendis will provide access to its …

Source: BioSpace - Label Pending
Published on 12:52 GMT

Novo Nordisk’s semaglutide shows promise in fatty liver disease MASH

Novo Nordisk has shared promising results from a late-stage study of semaglutide in patients with metabolic dysfunction-associated steatohepatitis (MASH), a progressive metabolic disease that affects the liver. The ongoing ESSENCE trial has been evaluating …

Source: PMLiVE - Neutral
Published on 21:56 GMT

Ozempic maker Novo Nordisk is working on a once-monthly weight-loss drug

Source: Quartz - Label Pending
Published on 19:27 GMT

A new weight loss pill outperformed Novo Nordisk's version

Source: Quartz - Label Pending
Published on 05:08 GMT

Weight loss drug industry injects wealth into Novo Nordisk home country

It has the ring of a Hans Christian Andersen fairytale—if a supremely ironic one. Tiny Denmark is home to six million of the world's wealthiest and healthiest people—all those muesli-munching cyclists…. even their letter O sometimes comes slashed in …

Source: CBS News - Neutral
Published on 05:08 GMT

With Novo Nordisk success, is there a "Nokia risk" for Denmark?

This week, 60 Minutes traveled to Denmark to report on Novo Nordisk, the pharmaceutical company that's behind the popular drugs Wegovy and Ozempic. Novo Nordisk's success with these drugs has led to huge profits: its current market capitalization …

Source: CBS News - Neutral
Published on 05:08 GMT

Novo Nordisk's obesity-fighting drugs fatten Denmark's economy

Novo Nordisk's blockbuster drugs Ozempic and Wegovy have slimmed down Hollywood stars and millions of non-celebrities worldwide — all while adding great heft to Denmark's economy. Novo Nordisk now has a market cap of $600 billion, injecting a …

Source: CBS News - Neutral
Published on 05:08 GMT

The Novo Nordisk scientist behind Ozempic, Wegovy weight loss research

Source: CBS News - Neutral
Published on 12:00 GMT

Ascendis Pharma and Novo Nordisk Sign Collaboration for Development and Commercialization of TransCon Technology-based ...

- Collaboration leverages Ascendis’ proprietary TransCon™ technologies and Novo Nordisk’s expertise in cardiometabolic diseases - Once-monthly GLP-1 receptor agonist will be the collaboration’s lead product candidate COPENHAGEN, Denmark, Nov. 04, 2024 ( …

Distribution channels:
Published on 11:05 GMT

Novo Nordisk reports positive data from part one of semaglutide trial for MASH

Novo Nordisk has reported positive outcomes from part one of the ESSENCE trial of semaglutide 2.4mg in treating metabolic dysfunction-associated steatohepatitis (MASH) and moderate to advanced liver fibrosis. The trial met its primary endpoints, showing a …

Source: Clinical Trials Arena - Label Pending